
Andrew Johns
Articles
-
Oct 9, 2024 |
digitalcommons.library.tmc.edu | Andrew Johns |Matthew Campbell |Mamie Gao |Andrew Hahn
BACKGROUND: Tivozanib has been approved as a third-line or later therapy for advanced renal cell carcinoma based on the TIVO-3 trial, which was conducted before immune checkpoint therapies (ICT), cabozantinib, and lenvatinib/everolimus became incorporated in the current sequential treatment paradigm for advanced clear cell RCC (ccRCC). METHODS: We performed a retrospective study of patients with advanced ccRCC treated with tivozanib at MD Anderson Cancer Center during 6/2021-7/2023.
-
Sep 25, 2024 |
smh.com.au | Andrew Johns
League columnist September 26, 2024 — 5.10am September 26, 2024 — 5.10am, register or subscribe to save articles for later. Add articles to your saved list and come back to them any time. Going into the first of the grand final qualifiers, I know which preparation I’d rather. The Storm have the huge advantage being fresh after a week off, while the Roosters have a six-day turnaround. Don’t underestimate how important it is at this time of year.
-
Jun 4, 2024 |
en.mogaznews.com | Andrew Johns
www.smh.com.au is blocked www.smh.com.au refused to connect.
-
May 22, 2024 |
en.mogaznews.com | Andrew Johns
We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand where our visitors are coming from.
-
May 15, 2024 |
smh.com.au | Andrew Johns
Can you imagine the imbalance he might have from one side of his body to the other? It was around his age, 26, that I started having my own problems. It comes from an accumulation of all the work you do and the overtraining. Brad Fittler started having problems with his groin at a similar age, and you can see even Cameron Munster is going through a tricky period in his career right now. Where Nathan has had his advantage for so long might also be part of the problem.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →